Technology Overview

About the Lumicell System


The Lumicell System was designed by leading engineers and scientists in partnership with leading breast cancer surgeons to fit seamlessly within the existing surgical workflow. The Lumicell System is in late-stage development for patients undergoing surgery for breast cancer and also under investigation for colorectal, esophageal cancers and brain metastases.


LUM015 is an optical contrast agent that targets the tumor microenvironment and is designed to fluoresce near cancer cells at the tumor margin when activated by proteases.


LUM 2.6 Imaging Device is a hand-held (15 cm x 3.1 cm), lightweight (500g) single-cell resolution imaging device, designed to fit into the lumpectomy cavity to scan for residual cancer at the margins. Proprietary decision software produces real-time images indicating location of residual cancer.